Literature DB >> 24710222

Robotic surgery twice performed in the treatment of hilar cholangiocarcinoma with deep jaundice: delayed right hemihepatectomy following the right-hepatic vascular control.

Zhenyu Zhu1, Quanda Liu, Junzhou Chen, Weihong Duan, Maosheng Dong, Peiyuan Mu, Di Cheng, Honglei Che, Tao Zhang, Xiaoya Xu, Ningxin Zhou.   

Abstract

OBJECTIVE: To explore and find a new method to treat hilar cholangiocarcinoma with deep jaundice assisted by Da Vinci robot.
METHODS: A hilar cholangiocarcinoma patient of type Bismuch-Corlette IIIa was found with deep jaundice (total bilirubin: 635 µmol/L). On the first admission, we performed Da Vinci robotic surgery including drainage of left hepatic duct, dissection of right hepatic vessels (right portal vein and right hepatic artery), and placement of right-hepatic vascular control device. Three weeks later on the second admission when the jaundice disappeared we occluded right-hepatic vascular discontinuously for 6 days and then sustained later. On the third admission after 3 weeks of right-hepatic vascular control, the right hemihepatectomy was performed by Da Vinci robot for the second time.
RESULTS: The future liver remnant after the right-hepatic vascular control increased from 35% to 47%. The volume of left lobe increased by 368 mL. When the total bilirubin and liver function were all normal, right hemihepatectomy was performed by Da Vinci robot 10 weeks after the first operation. The removal of atrophic right hepatic lobe with tumor in bile duct was found with no pathologic cancer remaining in the margin. The patient was followed up at our outpatient clinic every 3 months and no tumor recurrence occurs by now (1 y).
CONCLUSIONS: Under the Da Vinci robotic surgical system, a programmed treatment can be achieved: first, the hepatic vessels were controlled gradually together with biliary drainage, which results in liver's partial atrophy and compensatory hypertrophy in the other part. Then a radical hepatectomy could be achieved. Such programmed hepatectomy provides a new treatment for patients of hilar cholangiocarcinoma with deep jaundice who have the possibility of radical heptolobectomy.

Entities:  

Mesh:

Year:  2014        PMID: 24710222     DOI: 10.1097/SLE.0b013e31828f708b

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  3 in total

Review 1.  Systematic review of perioperative and oncologic outcomes of minimally-invasive surgery for hilar cholangiocarcinoma.

Authors:  Federica Cipriani; Francesca Ratti; Guido Fiorentini; Raffaella Reineke; Luca Aldrighetti
Journal:  Updates Surg       Date:  2021-02-22

2.  Minimally invasive surgery for perihilar cholangiocarcinoma: a systematic review.

Authors:  L C Franken; M J van der Poel; A E J Latenstein; M J Zwart; E Roos; O R Busch; M G Besselink; T M van Gulik
Journal:  J Robot Surg       Date:  2019-05-02

3.  The role of robotic surgery for the treatment of hilar cholangiocarcinoma: A systematic review.

Authors:  Alberto Brolese; Marta Rigoni; Alessio Pasquale; Giovanni Viel; Marco Brolese; Francesco Antonio Ciarleglio
Journal:  Front Oncol       Date:  2022-09-28       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.